Eldecalcitol effects on osteoblastic differentiation and function in the presence or absence of osteoclastic bone resorption

Eldecalcitol (ELD) is an active vitamin D3 analog, possesses anti-resorption properties and is an approved therapeutic drug for the treatment of osteoporosis in Japan. However, the effect of ELD on osteoblasts in a distinct cell microenvironment, including in the presence or absence of osteoclastic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bu, Jie, Du, Juan, Shi, Lina, Feng, Wei, Wang, Wei, Guo, Jie, Hasegawa, Tomoka, Liu, Hongrui, Wang, Xuxia, Li, Minqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676146/
https://www.ncbi.nlm.nih.gov/pubmed/31410166
http://dx.doi.org/10.3892/etm.2019.7784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676146/
https://www.ncbi.nlm.nih.gov/pubmed/31410166
http://dx.doi.org/10.3892/etm.2019.7784

Ejemplares similares